IPO registrations (S-1, F-1) · Registrants

AGENUS INC

SEC CIK

1098972 · filings on EDGAR ↗

Name on the registration

ANTIGENICS INC /DE/

Former names

ANTIGENICS INC /DE/ (1999–2011)

Registration

Form S-1, first filed 1999-11-30, last 2009-08-21; 4 initial registrations, 6 amendments

Outcome

Final prospectus filed 2000-02-04; declared effective 2007-01-29

Industry (SIC)

Biological Products, (No Diagnostic Substances) 2836

Incorporated in

DE

Business address

3 FORBES ROAD, Lexington, MA 02421

EIN

06-1562417

Ticker

AGEN (Nasdaq)

EDGAR entity type

operating

Insiders and CEO pay

AGENUS INC on the corporate pages

Offering terms

Final price

$5.89 per share (424B4 filed 2000-02-04, an initial public offering)

Shares sold

3,500,000

Gross proceeds

$20,615,000 before underwriting discounts and any over-allotment option

Lead underwriters

Piper Sandler; Robertson Stephens (940,000 shares)

Syndicate

BofA Securities (115,000); CIBC World Markets (115,000); J.P. Morgan (115,000); Lehman Brothers (115,000); Merrill Lynch (115,000); Morgan Stanley (115,000); Prudential Securities (115,000); Citigroup (115,000); Cowen (115,000); Nessuah Zannex Ltd (115,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: Agenus Inc. Fuzzy (name and state)
• Form 5500 plan sponsor: AGENUS INC. EXACT (EIN (EXACT))
• Federal award recipient: AGENUS INC. Fuzzy (name and state)
• Form D issuer: AGENUS INC EXACT (CIK (EXACT))
• Lobbying client: AGENUS INC. Fuzzy (name and state)
• SEC filer: AGENUS INC EXACT (CIK (EXACT))
• Person page: Garo H Armen Phd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
• Person page: Paul N Clark Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))

Filings 26

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), MA first:

• TRANSCEND THERAPEUTICS INC MA
• Eloxx Pharmaceuticals, Inc. MA
• PANACOS PHARMACEUTICALS, INC. MA
• CHARLES RIVER LABORATORIES INC MA
• CURIS INC MA
• MOMENTA PHARMACEUTICALS INC MA
• ACCELERON PHARMA INC MA
• bluebird bio, Inc. MA
• Altus Pharmaceuticals Inc. MA
• BioVex Group, Inc. MA

More with this interest.

In other datasets, the same topic (Health) in MA:

• Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health